HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Cheng Selected Research

Type I Keratins (Type I Keratin)

1/2022Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Cheng Research Topics

Disease

128Neoplasms (Cancer)
10/2022 - 03/2003
29Infections
02/2023 - 08/2009
22Breast Neoplasms (Breast Cancer)
01/2022 - 03/2010
19Inflammation (Inflammations)
01/2022 - 11/2015
16Alzheimer Disease (Alzheimer's Disease)
01/2021 - 10/2009
13Hypoxia (Hypoxemia)
08/2022 - 07/2012
13Melanoma (Melanoma, Malignant)
06/2022 - 03/2009
13Glioma (Gliomas)
04/2022 - 08/2010
13Stroke (Strokes)
12/2021 - 06/2005
12Carcinoma (Carcinomatosis)
01/2022 - 09/2008
12Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 01/2015
11Ischemia
12/2020 - 08/2011
10Cognitive Dysfunction
08/2018 - 02/2014
10Myocardial Infarction
02/2018 - 06/2005
8Hepatocellular Carcinoma (Hepatoma)
10/2022 - 03/2006
8Neoplasm Metastasis (Metastasis)
06/2022 - 08/2009
8Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 01/2012
8Reperfusion Injury
08/2021 - 01/2012
8Carcinogenesis
03/2021 - 10/2007
7Lung Injury
01/2021 - 10/2018
7Atherosclerosis
03/2020 - 08/2008
7Thrombosis (Thrombus)
01/2020 - 04/2005
6Prostatic Neoplasms (Prostate Cancer)
08/2022 - 01/2014
6Parkinson Disease (Parkinson's Disease)
01/2022 - 11/2013
6Infarction (Infarctions)
12/2021 - 08/2011
6Ischemic Stroke
12/2021 - 06/2008
6Brain Ischemia (Cerebral Ischemia)
08/2021 - 01/2010
6Hypersensitivity (Allergy)
10/2020 - 11/2006
6Amyloid Plaque
02/2016 - 10/2010
5Adenocarcinoma
08/2022 - 10/2007
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 01/2018
5Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022 - 01/2016
5Insulin Resistance
12/2021 - 09/2013
5Stomach Neoplasms (Stomach Cancer)
01/2021 - 04/2012
5Dementia (Dementias)
01/2021 - 02/2014
5Gestational Diabetes (Gestational Diabetes Mellitus)
01/2020 - 03/2010
5Necrosis
09/2019 - 10/2011
5Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2018 - 05/2010
4Endometriosis
06/2022 - 01/2017
4Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2020
4Obesity
01/2022 - 01/2016
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2021 - 01/2010
4Multiple Myeloma
01/2021 - 01/2019
4Fibrosis (Cirrhosis)
01/2021 - 07/2012
4Acute Lung Injury
01/2021 - 10/2014
4Heart Failure
10/2020 - 07/2010

Drug/Important Bio-Agent (IBA)

52Proteins (Proteins, Gene)FDA Link
10/2022 - 10/2007
25Pharmaceutical PreparationsIBA
02/2023 - 04/2005
18Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2008
15MicroRNAs (MicroRNA)IBA
01/2021 - 04/2011
12EnzymesIBA
06/2022 - 02/2013
11Small Interfering RNA (siRNA)IBA
06/2020 - 04/2011
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2020 - 07/2010
11Messenger RNA (mRNA)IBA
08/2019 - 05/2004
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 03/2009
9Long Noncoding RNAIBA
04/2022 - 12/2015
9Therapeutic UsesIBA
01/2022 - 01/2016
9Oxygen (Dioxygen)IBA
01/2021 - 09/2012
9Biological ProductsIBA
01/2021 - 05/2008
8CytokinesIBA
01/2022 - 08/2008
7Transcription Factors (Transcription Factor)IBA
01/2022 - 03/2006
7AntioxidantsIBA
01/2021 - 03/2019
7Phosphotransferases (Kinase)IBA
11/2018 - 03/2010
6Retinaldehyde (Retinal)IBA
01/2022 - 05/2004
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2003
6Interleukin-6 (Interleukin 6)IBA
01/2021 - 07/2010
6Beclin-1IBA
08/2020 - 08/2010
5Estrogen ReceptorsIBA
08/2022 - 01/2012
5Circular RNAIBA
03/2022 - 04/2018
5oridoninIBA
08/2021 - 03/2009
5Cisplatin (Platino)FDA LinkGeneric
07/2021 - 05/2016
5AlloysIBA
02/2021 - 02/2009
5LigandsIBA
01/2021 - 02/2011
5RNA (Ribonucleic Acid)IBA
01/2021 - 01/2012
5Indicators and Reagents (Reagents)IBA
01/2021 - 06/2014
5Adenosine Triphosphate (ATP)IBA
11/2020 - 03/2010
5SurvivinIBA
01/2020 - 08/2010
5TamoxifenFDA LinkGeneric
01/2020 - 05/2009
5salicylhydroxamic acid (SHAM)IBA
01/2019 - 09/2012
5Amyloid (Amyloid Fibrils)IBA
01/2017 - 01/2013
5benzofuranIBA
01/2013 - 10/2010
4CateninsIBA
10/2022 - 01/2016
4IronIBA
01/2022 - 06/2016
4Elongation Factor 2 KinaseIBA
01/2022 - 02/2013
4Neuroprotective AgentsIBA
12/2021 - 08/2011
4LipidsIBA
12/2021 - 05/2010
4Chloroquine (Aralen)FDA LinkGeneric
10/2021 - 03/2013
41-phenyl-3,3-dimethyltriazene (PDT)IBA
05/2021 - 01/2017
4Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2021 - 01/2012
4Glutathione (Reduced Glutathione)IBA
01/2021 - 01/2017
4Sirtuin 3IBA
01/2021 - 09/2013
4Anti-Bacterial Agents (Antibiotics)IBA
10/2020 - 02/2012

Therapy/Procedure

69Therapeutics
08/2022 - 04/2005
8Drug Therapy (Chemotherapy)
05/2022 - 06/2015
8Immunotherapy
01/2022 - 01/2018
7Radiotherapy
01/2022 - 01/2016
7Photochemotherapy (Photodynamic Therapy)
10/2021 - 10/2013
7Lasers (Laser)
01/2021 - 10/2007
6Transplantation
01/2021 - 02/2016
6Stents
12/2019 - 07/2012